F Fuzkk Atlas of Asia, the Middle East, Canada, Australia and Africa
#22FUZKK atlas leaders 1–100

Celltrion

South Korea · East Asia

Diversified pharmaBiologics

Manufacturing profile

Diversified pharma
Biologics

Country: South Korea

Macro-region: East Asia

Selection basis

The company is placed in positions 1–100 as a major manufacturer, biopharmaceutical group, generics/API/CDMO leader or a significant regional manufacturing participant.

The Top 300 is a FUZKK atlas priority rather than a single official revenue table. China, India, Israel, the USA and the European scope are excluded because separate atlases already cover them.

Representative manufacturing and QC chain

  1. 1Portfolio of products and manufacturing sites
  2. 2Multiple manufacturing process types
  3. 3Shared supplier, validation and data controls
  4. 4Product-specific and instrumental QC
  5. 5Group QMS, release and lifecycle evidence
  6. 6Cell bank or microbial seed
  7. 7Upstream culture or fermentation
  8. 8Clarification and chromatography
  9. 9UF/DF, formulation and sterile filtration

Relevant FUZKK packages

South Korea: national essential medicines QC packageChina: national essential medicines QC packageLumex QC SuiteLabEx QC SuiteMedical Device QMS SuiteGlobal API & Biosimilars QC Suite

Product/API utilities

Assay & Impurities Result ReviewerResidual Host Cell DNA Quality CheckerResidual Host Protein Checker

Lumex — instrumental QC

Genotoxic Impurity Screener M7Content Uniformity Acceptance ValueSystem Suitability Parameters CheckerCE Glycosylation Profiler

LabEx — laboratory QC

Assay & Impurity HPLC Quality CheckerResidual Solvents GC Quality CheckerWater Content KF Quality CheckerBiologic Aggregate Size Quality CheckerCharge Variant CE Quality CheckerProtein Concentration UV Quality CheckerELISA Bioassay Quality CheckerSPR Binding Affinity Quality CheckerEndotoxin Biologic Product Quality CheckerAutomated Sterility Detection Quality Checker

Medical Devices — equipment and software lifecycle

Release Readiness CheckerSupplier Evaluation CheckerCalibration Status CheckerProcess Validation CheckerChange Control Impact CheckerData Integrity Security CheckerRequirement Traceability Checker

Suggested first pilot

  1. Confirm one real product, method or recurring QC review.
  2. Record the instrument, export format and current specification.
  3. Select 3–7 utilities from the map above.
  4. Run a PASS/FAIL sample and agree the expected output.
  5. After user validation, expand to other products and sites.

Mapping boundary

The Top 300 is a FUZKK atlas priority rather than a single official revenue table. China, India, Israel, the USA and the European scope are excluded because separate atlases already cover them.

Methodology